相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genomic correlates of response to immune checkpoint blockade
Tanya E. Keenan et al.
NATURE MEDICINE (2019)
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial
Brian I. Rini et al.
LANCET (2019)
Correlate tumor mutation burden with immune signatures in human cancers
Xiaosheng Wang et al.
BMC IMMUNOLOGY (2019)
Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
Jun Wang et al.
CELL (2019)
Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression
C. Van Berckelaer et al.
BREAST CANCER RESEARCH (2019)
Circulating Lymphocytes, PD-L1 Expression on Tumor-infiltrating Lymphocytes, and Survival of Colorectal Cancer Patients with Different Mismatch Repair Gene Status
Pengfei Kong et al.
JOURNAL OF CANCER (2019)
Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients
Xiaofang Xing et al.
ONCOIMMUNOLOGY (2018)
Mechanisms of Resistance to PD-1 and PD-L1 Blockade
Theodore S. Nowicki et al.
CANCER JOURNAL (2018)
Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade
Sachet A. Shukla et al.
CELL (2018)
LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival
Sigurd M. Hald et al.
CLINICAL LUNG CANCER (2018)
CD274, LAG3, and IDO1 expressions in tumor-infiltrating immune cells as prognostic biomarker for patients with MSI-high colon cancer
Soo Jung Lee et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Tissue-Specific Immunoregulation: A Call for Better Understanding of the Immunostat in the Context of Cancer
William Pao et al.
CANCER DISCOVERY (2018)
PD-L1 expression and CD8-positive T cells are associated with favorable survival in HER2-positive invasive breast cancer
Yanjun Hou et al.
BREAST JOURNAL (2018)
Soluble LAG3 acts as a potential prognostic marker of gastric cancer and its positive correlation with CD8+T cell frequency and secretion of IL-12 and INF-γ in peripheral blood
Na Li et al.
CANCER BIOMARKERS (2018)
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
Diana Miao et al.
NATURE GENETICS (2018)
Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy
Jean-David Fumet et al.
BRITISH JOURNAL OF CANCER (2018)
Expression of programmed cell death ligand 1 and immune checkpoint markers in residual tumors after neoadjuvant chemotherapy for advanced high-grade serous ovarian cancer
Hyun-Soo Kim et al.
GYNECOLOGIC ONCOLOGY (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Expression of TIM-3 and LAG-3 in extranodal NK/T cell lymphoma, nasal type
Yuhua Feng et al.
HISTOLOGY AND HISTOPATHOLOGY (2018)
Inflammatory Reprogramming with IDO1 Inhibitors: Turning Immunologically Unresponsive 'Cold' Tumors 'Hot'
George C. Prendergast et al.
TRENDS IN CANCER (2018)
Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer
Y. Sunakawa et al.
PHARMACOGENOMICS JOURNAL (2017)
LAG3 (CD223) as a cancer immunotherapy target
Lawrence P. Andrews et al.
IMMUNOLOGICAL REVIEWS (2017)
LAG-3 Protein Expression in Non-Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes
Yayi He et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
Arjun V. Balar et al.
LANCET (2017)
TIM-3 is a potential prognostic marker for patients with solid tumors: A systematic review and meta-analysis
Yang Zhang et al.
ONCOTARGET (2017)
Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
Jon Bjoern et al.
ONCOTARGET (2017)
Transcriptomic immunologic signature associated with favorable clinical outcome in basal-like breast tumors
Sandra Martinez-Canales et al.
PLOS ONE (2017)
LAG-3+tumor infiltrating lymphocytes in breast cancer: clinical correlates and association with PD-1/PD-L1+tumors
S. Burugu et al.
ANNALS OF ONCOLOGY (2017)
PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma
Ombretta Melaiu et al.
CLINICAL CANCER RESEARCH (2017)
Combination cancer immunotherapies tailored to the tumour microenvironment
Mark J. Smyth et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Lymphocyte-activation gene-3, an important immune checkpoint in cancer
Yayi He et al.
CANCER SCIENCE (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
Prognostic relevance of genetic variants involved in immune checkpoints in patients with colorectal cancer
Shinkyo Yoon et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst et al.
LANCET (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers
Giulia Bottai et al.
BREAST CANCER RESEARCH (2016)
Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis
Haiming Yu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer
Nicolas A. Giraldo et al.
CLINICAL CANCER RESEARCH (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Variations in genes involved in immune response checkpoints and association with outcomes in patients with resected colorectal liver metastases
S. Stremitzer et al.
PHARMACOGENOMICS JOURNAL (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
TIMgenes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity
Gordon J. Freeman et al.
IMMUNOLOGICAL REVIEWS (2015)
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
Sylvia Adams et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The effect of immune microenvironment on the progression and prognosis of colorectal cancer
Jinxiang Chen et al.
MEDICAL ONCOLOGY (2014)
Lymphocyte Activation Gene-3 (LAG-3) Negatively Regulates Environmentally-Induced Autoimmunity
Vibha Jha et al.
PLOS ONE (2014)
Mechanisms of disseminated cancer cell dormancy: an awakening field
Maria Soledad Sosa et al.
NATURE REVIEWS CANCER (2014)
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Seng-Ryong Woo et al.
CANCER RESEARCH (2012)
A soluble lymphocyte activation gene-3 (sLAG-3) protein as a prognostic factor in human breast cancer expressing estrogen or progesterone receptors
F Triebel et al.
CANCER LETTERS (2006)
Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo
CJ Workman et al.
JOURNAL OF IMMUNOLOGY (2004)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Systematic reviews in health care - Systematic reviews of evaluations of diagnostic and screening
JJ Deeks
BRITISH MEDICAL JOURNAL (2001)
分享论文
